NCT00676585View on ClinicalTrials.gov

Corticosteroid Therapy in Refractory Shock Following Cardiac Arrest

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Cardiac Arrest
Interventions
DRUG

Normal Saline

Normal Saline

DRUG

Hydrocortisone

Hydrocortisone 100mg

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

Beth Israel Deaconess Medical Center

OTHER

NCT00676585 - Corticosteroid Therapy in Refractory Shock Following Cardiac Arrest | Biotech Hunter | Biotech Hunter